Humanigen Signs Agreement With MD Anderson Cancer Center to Begin Research Investigating Lenzilumab as CAR-T Support Pharmaceutical Investing
Apricus Biosciences Announces Outcome of Vitaros™ End-of-Review Meeting with FDA Pharmaceutical Investing
Cyclacel Announces Presentation of Phase 1 Clinical Data for CDK Inhibitor CYC065 at AACR 2018 Annual Meeting Pharmaceutical Investing
Celldex’s METRIC Study in Metastatic Triple-negative Breast Cancer Does Not Meet Primary Endpoint Genetics Investing
G1 Therapeutics Announces Initiation of Phase 1b/2 Clinical Trial of G1T38 in Combination with Tagrisso for EGFR-Mutant Non-Small Cell Lung Cancer Biotech Investing
Telix Pharmaceuticals, INSERM and ARRONAX Enter into Translational Research Partnership Biotech Investing
NewLink Genetics Announces Initial Phase 1 Data with Indoximod Plus Radiation and Chemotherapy for Pediatric Patients Genetics Investing
Xanthic Biopharma Inc. Commends The U.S. Federal Government’s Promise To Protect States That Have Legalized Cannabis Cannabis Investing News
ChroMedX Appoints Michaela Shaw as Director of Quality Assurance and Regulatory Assurance Medical Device Investing
Progressive Care Reports 20% Increase in Year over Year Prescriptions Filled During March 2018 Pharmaceutical Investing
